Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Angelo Filosa Ph.D.
More GEN Content From This Contributor
- BioPerspectives: A Case for Co-Sourcing
- BioPerspectives: A New Approach to Laboratory Efficiency: On-Site Instrument Concierge Service
- BioPerspectives: Managing Laboratory Consumables
- BioPerspectives: The “New Normal” in Laboratory Efficiency: Leaner, Faster, Smarter
- GEN Exclusives: Putting the Focus Back on Drug Discovery with Co-Sourcing